Trial description
A Double-Blind, Phase III, Randomised Study to Compare the Efficacy and Safety of Oral Azacitidine (CC-486) Versus Placebo in Subjects with Acute Myeloid Leukaemia or Myelodysplastic Syndromes as Maintenance after Allogeneic Haematopoietic Stem Cell Transplantation
Contact name
Dr Charles Crawley
Trial start date
Thursday, December 19, 2019
Trial end date
Saturday, December 31, 2022
Trial tumour type
Show on Radiotherapy